Management of Non-Muscle Invasive Bladder Cancer

This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.

Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.

Cover

Front Matter

?‚? Part I. Background and Pathology on Bladder Cancer

?‚?

1. Background on Bladder Cancer

?‚?

2. Introduction to Bladder Cancer Type and Therapy

?‚? Part II. Histological Variants in Bladder Cancer

?‚?

3. Histological Variants in Bladder Cancer?€”Sqaumous Cell Carcinoma and Squamous Differentiation

?‚?

4. Histological Variants in Bladder Cancer?€”Adenocarcinoma

?‚?

5. Histological Variants in Bladder Cancer?€”Sarcomatoid Differentiation

?‚?

6. Histological Variants in Bladder Cancer?€”Carcinosarcoma

?‚?

7. Histological Variants in Bladder Cancer?€”Small Cell Carcinoma

?‚?

8. Histological Variants?€”Plasmacytoid Bladder Cancer

?‚? Part III. Epidemiology and Risk Factors in Bladder Cancer

?‚?

9. Introduction to Epidemiology of Bladder Cancer

?‚?

10. Epidemiology, Risk Factors and Occupational Hazards?€”A Systematic Review

?‚?

11. Systematic Review Results on Bladder Cancer Epidemiology, Occupational Hazards and Risk Factors

?‚? Part IV. Assessment and Diagnostics in NMIBC

?‚?

12. Bladder Cancer?€”Diagnostic Pathways

?‚?

13. Systematic Review Method?€”Bladder Cancer Screening

?‚?

14. Bladder Cancer Screening?€”Systematic Review Results

?‚?

15. Bladder Cancer Screening Systematic Review Conclusion

?‚?

16. Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening

?‚?

17. Usefulness of Screening in Bladder Cancer

?‚? Part V. Techniques in Endoscopic Resection

?‚?

18. Management of Non-Muscle Invasive Bladder Cancer

?‚?

19. A New Technique?€”En Bloc Resection of Bladder Tumours

?‚?

20. Prognostic Factors for Endoscopic Resection in NMIBC

?‚?

21. NMIBC and Oncological Outcomes from Endoscopic Resection

?‚?

22. Recurrence in NMIBC

?‚?

23. Definitive Treatment in NMIBC

?‚?

24. A Systematic Review of En-Bloc Resection

?‚?

25. Systematic Review?€”Results from En-Bloc Resection of Bladder Cancer

?‚? Part VI. Management of Low and Intermediate Risk Bladder Cancer

?‚?

26. NMIBC?€”Fulguration in Low Risk Disease

?‚?

27. Active Surveillance in Non-Muscle Invasive Bladder Cancer

?‚?

28. Hyperthermic MMC?€”A Systematic Review

?‚?

29. Literature Related to Hyperthermic MMC

?‚? Part VII. Management of High Risk Non-Muscle Invasive Bladder Cancer

?‚?

30. BCG?€”Patterns of Administration

?‚?

31. NMIBC?€”BCG Strain and Outcomes

?‚?

32. Adverse Effects in BCG Therapy

?‚?

33. BCG and Elderly Patients

?‚?

34. A Systematic Review of NMIBC and Intravesical Chemotherapy

?‚?

35. A Systematic Review of NMIBC and Intravesical Chemotherapy?€”Results

?‚?

36. What the Literature Says Re BCG

?‚?

37. Prognostic Factors in BCG

?‚?

38. Intermediate and High Risk NMIBC and BCG

?‚?

39. NMIBC, Low Dose BCG and High-Risk Disease

?‚?

40. Alternatives to BCG Therapy?€”MMC

?‚?

41. BCG Versus Mitomycin C?€”A Systematic Review

?‚?

42. What the Literature Says NMIBC?€”BCG or MMC

?‚?

43. NMIBC and Intravesical Chemotherapy?€”HIVEC I and HIVEC II

?‚?

44. BCG Refractory Disease?€”Oncological Outcomes

?‚?

45. NMIBC?€”High Grade BCG Refractory Disease

?‚?

46. A Systematic Review on Alternatives in BCG Refractory Disease

?‚?

47. Systematic Review Results on BCG Refractory Disease Management

?‚?

48. What the Literature Says on BCG Refractory Disease and Alternatives

?‚?

49. NMIBC?€”BCG Refractory Disease and Use of Interferon

?‚?

50. Novel Agents in BCG Refractory Disease

?‚?

51. A Scoring System for Intravesical Therapy and NMIBC

?‚?

52. High Risk NMIBC and TURBT

?‚?

53. G3T1 Bladder Cancer: Cystectomy Versus BCG

?‚?

54. A Systematic Review of High-Grade Bladder Cancer?€”Methods

?‚?

55. Systematic Review of G3T1 Bladder Cancer

?‚?

56. Radical Cystectomy in High Grade NMI Bladder Cancer

?‚? Part VIII. Bladder Cancer in the Elderly and Females

?‚?

57. Bladder Cancer in the Elderly

?‚?

58. Systematic Review on Bladder Cancer Management in Elderly Patients

?‚?

59. Systematic Review?€”Results on Bladder Cancer Management in the Elderly

?‚?

60. Reviews Relating to Management of Bladder Cancer in the Elderly

?‚?

61. Female Outcomes in Bladder Cancer

?‚?

62. A Systematic Review on Bladder Cancer and Female Gender

?‚?

63. Systematic Review Results on Bladder Cancer and Female Gender

?‚?

64. Reviews on Female Gender and Bladder Cancer

?‚? Part IX. Bladder Cancer Survivorship

?‚?

65. Definition of Bladder Cancer Survivorship

?‚?

66. The Impact of Bladder Cancer Survivorship

?‚?

67. Unmet Needs in Bladder Cancer Survivorship

?‚?

68. Systematic Review?€”Bladder Cancer Survivorship?€”Unmet Needs

?‚?

69. Systematic Review Search Results?€”Bladder Cancer Survivorship and Unmet Need

?‚?

70. Survivorship Challenges in Non-Muscle Invasive Bladder Cancer

?‚?

71. Bladder Cancer Survivorship Care Plans

?‚?

72. Research Summary?€”A New Model of Care for Patients with Bladder Cancer (MODA)

?‚?

73. What Is the Impact of Sexual and Emotional Concerns on Patients Post Surgery for Patients with Bladder Cancer?

?‚?

74. Results?€”Telephone Interviews with Thematic Analyses

?‚?

75. Bladder Cancer Survivorship and Patient Reported Outcome Measures?€”Code 1 Erectile Dysfunction

?‚?

76. Bladder Cancer Survivorship and Patient Reported Outcome Measures?€”Code 2 Age Related Disease

?‚?

77. Bladder Cancer Survivorship and Patient Reported Outcome Measures?€”Code 3 Side Effects Post Operatively

?‚?

78. Bladder Cancer Survivorship and Patient Reported Outcome Measures?€”Code 4 Psychological Impact

?‚?

79. Bladder Cancer Survivorship and Patient Reported Outcome Measures?€”Code 5 Impact of Operation on General Health

?‚?

80. Bladder Cancer Survivorship Tool

?‚?

81. Health Related Quality of Life Measurements in Bladder Cancer Survivorship

Back Matter